4/22/2010

Covidien reported a double-digit increase in radiopharmaceutical sales for the fiscal second quarter driven in part by an increase in thallium sales. Overall pharmaceutical sales, however, were down for the quarter, the company said. Sales of contrast products also decreased.

Related Summaries